53 H2Oil2 study protocol 3 REFERENCES 1. Mascarenhas MN, Flaxman SR, Boerma T, Vanderpoel S, Stevens GA. National, regional, and global trends in infertility prevalence since 1990: a systematic analysis of 277 health surveys. PLoS Med. 2012;9(12):e1001356. 2. Zegers-Hochschild F, Adamson GD, Dyer S, Racowsky C, de Mouzon J, Sokol R, et al. The International Glossary on Infertility and Fertility Care, 2017. Hum Reprod. 2017;32(9):1786801. 3. ACOG. Infertility Workup for the Women’s Health Specialist. Obstetrics and Gynecology. 2019;133:377-84. 4. NICE. Fertility assessment and treatment for people with fertility problems. 2013 01-022013. Contract No.: CG 156 2013. 5. Mills M, Rindfuss RR, McDonald P, te Velde E, Reproduction E, Society Task F. Why do people postpone parenthood? Reasons and social policy incentives. Hum Reprod Update. 2011;17(6):848-60. 6. Hoenderboom BM, van Benthem BHB, van Bergen J, Dukers-Muijrers N, Gotz HM, Hoebe C, et al. Relation between Chlamydia trachomatis infection and pelvic inflammatory disease, ectopic pregnancy and tubal factor infertility in a Dutch cohort of women previously tested for chlamydia in a chlamydia screening trial. Sex Transm Infect. 2019;95(4):300-6. 7. Trimbos-Kemper T, Trimbos B, van Hall E. Etiological factors in tubal infertility. Fertility and Sterility. 1982;37(3):384-8. 8. Taylor E, Gomel V. The uterus and fertility. Fertil Steril. 2008;89(1):1-16. 9. Practice Committee of the American Society for Reproductive M. Effectiveness and treatment for unexplained infertility. Fertil Steril. 2006;86(5 Suppl 1):S111-4. 10. Bhattacharya S, Porter M, Amalraj E, Templeton A, Hamilton M, Lee AJ, et al. The epidemiology of infertility in the North East of Scotland. Hum Reprod. 2009;24(12):3096-107. 11. Roest I, van Welie N, Mijatovic V, Dreyer K, Bongers M, Koks C, et al. Complications after hysterosalpingography with oil- or water-based contrast: results of a nationwide survey. Hum Reprod Open. 2020;2020(1):hoz045. 12. Wang R, van Welie N, van Rijswijk J, Johnson NP, Norman RJ, Dreyer K, et al. Effectiveness on fertility outcome of tubal flushing with different contrast media: systematic review and network meta-analysis. Ultrasound Obstet Gynecol. 2019;54(2):172-81. 13. Fang F, Bai Y, Zhang Y, Faramand A. Oil-based versus water-based contrast for hysterosalpingography in infertile women: a systematic review and meta-analysis of randomized controlled trials. Fertil Steril. 2018(110):153-60. 14. Wang R, Watson A, Johnson N, Cheung K, Fitzgerald C, Mol BWJ, et al. Tubal flushing for subfertility. Cochrane Database Syst Rev. 2020;10:CD003718. 15. Dreyer K, van Rijswijk J, Mijatovic V, Goddijn M, Verhoeve HR, van Rooij IAJ, et al. Oil-Based or Water-Based Contrast for Hysterosalpingography in Infertile Women. N Engl J Med. 2017;376(21):2043-52. 16. van Rijswijk J, van Welie N, Dreyer K, Pham CT, Verhoeve HR, Hoek A, et al. Tubal flushing with oil-based or water-based contrast at hysterosalpingography for infertility: long-term reproductive outcomes of a randomized trial. Fertility and Sterility. 2020;114(1):155-62. 17. Lindequist S, Rasmussen F, Larsen C. Use of Iotrolan versus Ethiodized Poppy-Seed Oil in Hysterosalpingography. Radiology. 1994;191:513-7. 18. Roest I, Rosielle K, van Welie N, Dreyer K, Bongers M, Mijatovic V, et al. Safety of oil-based contrast medium for hysterosalpingography: a systematic review. Reproductive BioMedicine Online. 2021;42(6):1119-29.
RkJQdWJsaXNoZXIy MTk4NDMw